Accelerating Access Initiative
A UN-Pharmaceutical Industry Partnership
Accelerating Access emerged out of the partnership initiated in May 2000 between the UN and five pharmaceutical companies (Boehringer Ingelheim GmbH, Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., Inc., and F. Hoffmann-La Roche Ltd.) to increase access to HIV/AIDS care, treatment, and support. As set out in the May 2000 Joint Statement of Intent, the UN/industry partnership was based on a set of broad principles, as follows: Unequivocal and ongoing political commitment by national governments. Strengthened national capacity. Engagement of all sectors of national society and the global community. Efficient, reliable, and secure distribution systems. Significant additional funding from new national…
